Golla Vishnukamal, Shan Yong, Mehta Hemalkumar B, Klaassen Zachary, Tyler Douglas S, Baillargeon Jacques, Kamat Ashish M, Freedland Stephen J, Gore John L, Chamie Karim, Kuo Yong-Fang, Williams Stephen B
Department of Urology, University of California, Los Angeles, CA, USA.
Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA.
Eur Urol Open Sci. 2020 Jun 23;19:27-36. doi: 10.1016/j.euros.2020.06.001. eCollection 2020 Jul.
One out of five patients with muscle-invasive bladder cancer undergo radical cystectomy-a guideline-recommended treatment. Previous studies have primarily evaluated patient characteristics associated with the use of radical cystectomy, ignoring potential nesting of data.
To determine the impact of patient, diagnosing urologist, and hospital characteristics on the variation in the use of radical cystectomy.
This is a retrospective cohort study using the Surveillance, Epidemiology, and End Results Registry (SEER)-Medicare linked database.
A total of 7097 muscle-invasive bladder cancer patients and 4601 diagnosing urologists affiliated to 822 hospitals from January 1, 2002 to December 31, 2012 were analyzed. Multilevel logistic regression analyses were used to determine variation and factors associated with the use of radical cystectomy.
Of the 7097 patients, only 27% underwent radical cystectomy. The intraclass correlation coefficient for variation in the use of radical cystectomy attributed to the hospital level was 4.3%. Higher radical cystectomy volume by diagnosing urologists (more than five vs zero to one surgery: odds ratio [OR], 1.27; 95% confidence interval [CI], 1.00-1.62) and hospitals (more than five vs zero to four surgeries: OR,1.48; 95% CI, 1.14-1.93) was associated with increased use of radical cystectomy. Patients diagnosed by female rather than male urologists were more likely to undergo radical cystectomy (OR, 1.32; 95% CI, 1.07-1.62).
We found that 4.3% variation in the use of radical cystectomy was attributed to the hospital level, leaving 95.7% variation in use unexplained. We identified significantly increased use among higher-volume and female diagnosing urologists. These findings support further investigation into measures beyond hospital volume, which largely impact the utilization of radical cystectomy.
In this large population-based study, we found that 4.3% of variation in the use of radical cystectomy was attributed to the hospital level, leaving 95.7% variation in use unexplained. Higher radical cystectomy volume of diagnosing urologists and female urologists were independently associated with increased use of radical cystectomy. These findings support further investigation into measures beyond hospital volume, which largely impact the utilization of radical cystectomy.
五分之一的肌层浸润性膀胱癌患者接受根治性膀胱切除术,这是一项指南推荐的治疗方法。以往研究主要评估与根治性膀胱切除术使用相关的患者特征,而忽略了数据可能存在的嵌套情况。
确定患者、诊断泌尿外科医生和医院特征对根治性膀胱切除术使用差异的影响。
设计、设置和参与者:这是一项使用监测、流行病学和最终结果登记处(SEER)-医疗保险链接数据库的回顾性队列研究。
分析了2002年1月1日至2012年12月31日期间822家医院的7097例肌层浸润性膀胱癌患者和4601名诊断泌尿外科医生。采用多水平逻辑回归分析来确定根治性膀胱切除术使用的差异及相关因素。
在7097例患者中,仅27%接受了根治性膀胱切除术。归因于医院层面的根治性膀胱切除术使用差异的组内相关系数为4.3%。诊断泌尿外科医生的根治性膀胱切除术手术量较高(超过5例与0至1例手术:比值比[OR],1.27;95%置信区间[CI],1.00 - 1.62)以及医院的手术量较高(超过5例与0至4例手术:OR,1.48;95%CI,1.14 - 1.93)与根治性膀胱切除术使用增加相关。由女性而非男性泌尿外科医生诊断的患者更有可能接受根治性膀胱切除术(OR,1.32;95%CI,1.07 - 1.62)。
我们发现根治性膀胱切除术使用差异的4.3%归因于医院层面,其余95.7%的使用差异无法解释。我们确定在手术量较高的诊断泌尿外科医生和女性泌尿外科医生中,根治性膀胱切除术的使用显著增加。这些发现支持对医院手术量之外的措施进行进一步研究,这些措施在很大程度上影响根治性膀胱切除术的应用。
在这项基于大样本人群的研究中,我们发现根治性膀胱切除术使用差异的4.3%归因于医院层面,其余95.7%的使用差异无法解释。诊断泌尿外科医生和女性泌尿外科医生的根治性膀胱切除术手术量较高与根治性膀胱切除术使用增加独立相关。这些发现支持对医院手术量之外的措施进行进一步研究,这些措施在很大程度上影响根治性膀胱切除术的应用。